| JAMA, The Journal of the American Medical Association 2001 Nader Rifai |
| Title | Subject | Authors |
|---|
| Ability of minor elevations of troponins I and T to predict benefit from an early invasive strategy in patients with unstable angina and non-ST elevation myocardial infarction: Results from a randomized trial. (ORIGINAL CONTRIBUTION). | Health | Paul T. DeLucca, Nader Rifai, Christopher P. Cannon, Eugene Braunwald, William S. Weintraub, Laura A. Demopoulos, Ralph Vicari, Martin J. Frey, Nasser Lakkis, Debbie H. Robertson, Peter M. DiBattiste, David A. Morrow, Darcy A. Hille |
| C-Reactive Protein, Interleukin 6, and Risk of Developing Type 2 Diabetes Mellitus. | Health | Paul M. Ridker, Julie E. Buring, Nader Rifai, Joann E. Manson, Aruna D. Pradhan |
| Effect of Statin Therapy on C-Reactive Protein Levels: A Randomized Trial and Cohort Study.(the Pravastatin Inflammation/CRP Evaluation (PRINCE) study) | Health | Nader Rifai, Michelle A. Albert, Ellie Danielson, Paul M Ridker |
| Novel Risk Factors for Systemic Atherosclerosis: A Comparison of C-Reactive Protein, Fibrinogen, Homocysteine, Lipoprotein(a), and Standard Cholesterol Screening as Predictors of Peripheral Arterial Disease. | Health | Paul M. Ridker, Nader Rifai, Meir J. Stampfer |
This website is not affiliated with document authors or copyright owners. This page is provided for informational purposes only. Unintentional errors are possible.
